These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 19936339

  • 1. 99mTc-MIBI whole body scintigraphy and P-glycoprotein for the prediction of multiple drug resistance in multiple myeloma patients.
    Fallahi B, Beiki D, Mousavi SA, Gholamrezanezhad A, Eftekhari M, Fard-Esfahani A, Alimoghaddam K, Mirpour S, Eskandarian A, Saghari M.
    Hell J Nucl Med; 2009; 12(3):255-9. PubMed ID: 19936339
    [Abstract] [Full Text] [Related]

  • 2. Multiple myeloma: predictive value of Tc-99m MIBI scintigraphy and MRI in its diagnosis and therapy.
    Myslivecek M, Nekula J, Bacovsky J, Scudla V, Koranda P, Kaminek M.
    Nucl Med Rev Cent East Eur; 2008; 11(1):12-6. PubMed ID: 19173182
    [Abstract] [Full Text] [Related]

  • 3. 99mTc-MIBI SPET in non-small cell lung cancer in relationship with Pgp and prognosis.
    Yüksel M, Cermik TF, Doğanay L, Karlikaya C, Cakir E, Salan A, Berkarda S.
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):876-81. PubMed ID: 12111127
    [Abstract] [Full Text] [Related]

  • 4. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
    Fonti R, Salvatore B, Quarantelli M, Sirignano C, Segreto S, Petruzziello F, Catalano L, Liuzzi R, Rotoli B, Del Vecchio S, Pace L, Salvatore M.
    J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
    [Abstract] [Full Text] [Related]

  • 5. Usefulness of 99mTc-sestamibi scintigraphy in suggesting the therapeutic effect of chemotherapy against gastric cancer.
    Kawata K, Kanai M, Sasada T, Iwata S, Yamamoto N, Takabayashi A.
    Clin Cancer Res; 2004 Jun 01; 10(11):3788-93. PubMed ID: 15173086
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Technetium-99m 2-methoxy-isobutyl-isonitrile uptake scintigraphy in detection of the bone marrow infiltration in multiple myeloma: correlation with MRI and other prognostic factors.
    Erten N, Saka B, Berberoglu K, Turkmen C, Unal S, Bakir B, Yekeler E, Besisik SK.
    Ann Hematol; 2007 Nov 01; 86(11):805-13. PubMed ID: 17684742
    [Abstract] [Full Text] [Related]

  • 8. The value of 99mTc-MIBI whole body scintigraphy in active and in remission multiple myeloma.
    Fallahi B, Saghari M, Fard Esfahani A, Eftekhari M, Iravani M, Beiki D, Dabbagh Kakhki VR, Sadeghi R.
    Hell J Nucl Med; 2005 Nov 01; 8(3):165-8. PubMed ID: 16390023
    [Abstract] [Full Text] [Related]

  • 9. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression.
    Burak Z, Moretti JL, Ersoy O, Sanli U, Kantar M, Tamgac F, Basdemir G.
    J Nucl Med; 2003 Sep 01; 44(9):1394-401. PubMed ID: 12960182
    [Abstract] [Full Text] [Related]

  • 10. Pgp inhibition by UIC2 antibody can be followed in vitro by using tumor-diagnostic radiotracers, 99mTc-MIBI and 18FDG.
    Krasznai ZT, Tóth A, Mikecz P, Fodor Z, Szabó G, Galuska L, Hernádi Z, Goda K.
    Eur J Pharm Sci; 2010 Dec 23; 41(5):665-9. PubMed ID: 20869436
    [Abstract] [Full Text] [Related]

  • 11. 99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients.
    Sergieva SB, Timcheva KV, Hadjiolov ND.
    J BUON; 2006 Dec 23; 11(1):61-8. PubMed ID: 17318954
    [Abstract] [Full Text] [Related]

  • 12. Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myeloma.
    Fonti R, Del Vecchio S, Zannetti A, De Renzo A, Catalano L, Pace L, Rotoli B, Salvatore M.
    Cancer Biother Radiopharm; 2004 Apr 23; 19(2):165-70. PubMed ID: 15186596
    [Abstract] [Full Text] [Related]

  • 13. TC-99m MIBI SPECT imaging in patients with lung carcinoma: is it a functional probe of multidrug resistance genes?
    Ak I, Gülbaş Z, Ocak S, Kaya E, Alataş F, Vardareli E, Metintaş M.
    J Comput Assist Tomogr; 2007 Apr 23; 31(5):795-9. PubMed ID: 17895794
    [Abstract] [Full Text] [Related]

  • 14. Technetium-99m-hexakis-2-methoxyisobutylisonitrile scintigraphy and multidrug resistance-related protein expression in human primary lung cancer.
    Duan XY, Wang JS, Liu M, Guo YM.
    Ann Nucl Med; 2008 Jan 23; 22(1):49-55. PubMed ID: 18250987
    [Abstract] [Full Text] [Related]

  • 15. Washout of [99mTc] sestamibi in predicting response to chemotherapy in patients with multiple myeloma.
    Pace L, Catalano L, Del Vecchio S, De Renzo A, Fonti R, Salvatore B, Andretta C, Di Nuzzo C, Rotoli B, Salvatore M.
    Q J Nucl Med Mol Imaging; 2005 Sep 23; 49(3):281-5. PubMed ID: 16172574
    [Abstract] [Full Text] [Related]

  • 16. In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance.
    Márián T, Szabó G, Goda K, Nagy H, Szincsák N, Juhász I, Galuska L, Balkay L, Mikecz P, Trón L, Krasznai Z.
    Eur J Nucl Med Mol Imaging; 2003 Aug 23; 30(8):1147-54. PubMed ID: 12830325
    [Abstract] [Full Text] [Related]

  • 17. Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy.
    Taki J, Sumiya H, Asada N, Ueda Y, Tsuchiya H, Tonami N.
    J Nucl Med; 1998 Jul 23; 39(7):1179-84. PubMed ID: 9669390
    [Abstract] [Full Text] [Related]

  • 18. Scintigraphy with technetium-99m methoxyisobutylisonitrile in multiple myeloma patients: correlation with the International Staging System.
    Koutsikos J, Grigoraki V, Athanasoulis T, Velidaki A, Mamoulakis C, Zomas A, Anagnostopoulos N, Georgiou E, Dimopoulos MA, Zerva C.
    Hell J Nucl Med; 2006 Jul 23; 9(3):177-80. PubMed ID: 17160159
    [Abstract] [Full Text] [Related]

  • 19. Technetium-99m sestamibi scintigraphy is sensitive and specific for the staging and the follow-up of patients with multiple myeloma: a multicentre study on 397 scans.
    Mele A, Offidani M, Visani G, Marconi M, Cambioli F, Nonni M, Catarini M, Brianzoni E, Berbellini A, Ascoli G, Brunori M, Agostini V, Corvatta L, Isidori A, Spinelli A, Gradari M, Leoni P.
    Br J Haematol; 2007 Mar 23; 136(5):729-35. PubMed ID: 17233770
    [Abstract] [Full Text] [Related]

  • 20. Technetium-99m-sestamibi scintigraphy in multiple myeloma and related gammopathies: a useful tool for the identification and follow-up of myeloma bone disease.
    Balleari E, Villa G, Garrè S, Ghirlanda P, Agnese G, Carletto M, Clavio M, Ferrando F, Gobbi M, Mariani G, Ghio R.
    Haematologica; 2001 Jan 23; 86(1):78-84. PubMed ID: 11146575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.